KARBE FRANK 4
4 · Phathom Pharmaceuticals, Inc. · Filed Dec 16, 2024
Insider Transaction Report
Form 4
KARBE FRANK
Director
Transactions
- Purchase
Common Stock
2024-12-13$7.93/sh+12,500$99,084→ 57,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.87 to $8.00. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.